Category: Top Story

  • JPMorgan Sees U.S. Earnings Outperforming Eurozone in Q3, Cyclicals Could Turn the Corner

    JPMorgan Sees U.S. Earnings Outperforming Eurozone in Q3, Cyclicals Could Turn the Corner

    The upcoming earnings season is expected to once again underscore the widening performance gap between U.S. and eurozone corporates, according to strategists at JPMorgan Chase & Co.. Consensus forecasts point to a 6% year-on-year increase in S&P 500 earnings, compared with a 1% decline for the STOXX Europe 600. Unlike the typical pre-earnings downgrades, analyst…

  • Earnings Season Becomes Crucial Test for AI-Driven Market Optimism, Barclays Warns

    Earnings Season Becomes Crucial Test for AI-Driven Market Optimism, Barclays Warns

    The third-quarter earnings season has arrived at a critical juncture for financial markets, shifting the focus from broad macroeconomic themes to AI-fueled optimism and company-level performance. According to strategists at Barclays, “earnings are set to take center stage, potentially pivotal for sustaining the rally,” making this a defining “show-me moment” for the AI-driven market narrative.…

  • Gold could reach $5,000 an ounce next year, say HSBC analysts

    Gold could reach $5,000 an ounce next year, say HSBC analysts

    HSBC analysts have lifted their price outlook for gold, projecting the precious metal could climb to $5,000 per ounce in 2026 as uncertainty across global markets deepens. In a note to clients, the brokerage said that the ongoing surge in gold prices will likely stretch into the first half of 2026, supported by its safe-haven…

  • Citi warns of more turbulence ahead for equity bull market

    Citi warns of more turbulence ahead for equity bull market

    Strategists at Citigroup, led by Beata Manthey, cautioned that the ongoing equity bull market may be heading into a choppier, more volatile stretch. They pointed to renewed tensions between the U.S. and China as a major source of uncertainty, emphasizing that “stakes are high and the path to resolution appears complex.” With earnings season picking…

  • Freeport-McMoRan to benefit from stronger copper and gold prices

    Freeport-McMoRan to benefit from stronger copper and gold prices

    HSBC upgraded Freeport-McMoRan (NYSE:FCX) to Buy from Hold and raised its price target to $50 from $43, citing a supportive environment for copper and gold prices that should bolster earnings, even as the miner faces operational setbacks at its flagship Grasberg mine in Indonesia. Copper has outperformed other base and bulk metals this year amid…

  • Taoping Inc. stock falls after announcing non-binding acquisition LOI

    Taoping Inc. stock falls after announcing non-binding acquisition LOI

    Taoping Inc. (NASDAQ:TAOP) shares dropped 8.4% in premarket trading on Friday after the company revealed it had signed a non-binding Letter of Intent (LOI) to acquire Alphalion Holding Limited. Under the proposed transaction, Taoping would acquire 100% of Alphalion’s equity. The deal remains contingent on due diligence, negotiation of a definitive agreement, and standard closing…

  • Protalix BioTherapeutics Inc stock plunges after CHMP rejects alternative Elfabrio dosing regimen

    Protalix BioTherapeutics Inc stock plunges after CHMP rejects alternative Elfabrio dosing regimen

    Protalix BioTherapeutics Inc (AMEX:PLX) shares tumbled 20.8% in premarket trading on Friday after the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a negative opinion on the company’s application to approve an alternative dosing schedule for its Fabry disease therapy Elfabrio. The CHMP rejected Protalix’s proposal for a…

  • Avita Medical Ltd stock tumbles after CEO exit and Board shake-up

    Avita Medical Ltd stock tumbles after CEO exit and Board shake-up

    Avita Medical Ltd (NASDAQ:RCEL) shares plunged 21.9% in premarket trading on Friday after the company announced a sudden leadership transition and major Board changes. The wound care therapeutics firm said Chairman Cary Vance has been appointed Interim Chief Executive Officer, replacing Jim Corbett, who is stepping down from both his CEO role and his seat…

  • XORTX Therapeutics Inc stock soars after acquiring renal anti-fibrotic program

    XORTX Therapeutics Inc stock soars after acquiring renal anti-fibrotic program

    XORTX Therapeutics Inc (NASDAQ:XRTX) shares surged 40% in premarket trading on Friday after the company announced it had signed a binding term sheet to acquire a Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems Limited. As part of the deal, the late-stage clinical pharmaceutical firm will gain rights to VB4-P5 — a novel new chemical entity…

  • Sealsq Corp stock soars after unveiling IC’Alps integration strategy

    Sealsq Corp stock soars after unveiling IC’Alps integration strategy

    Sealsq Corp (NASDAQ:LAES) shares climbed 10.2% in premarket trading on Friday after the company revealed its integrated strategy for IC’Alps, the French ASIC design house it recently acquired. The plan positions Sealsq as the only firm able to provide secure hardware solutions across Catalog ICs, Custom ICs, and Security IP. The semiconductor and post-quantum cryptography…